JarvinenHJAarnioMMustonenH. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology2000;118:829–834.
JarvinenHJRenkonen-SinisaloLAktan-CollanK. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol2009;27:4793–4797.
WalshTLeeMKCasadeiS. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci U S A2010;107:12629–12633.
CragunDRadfordCDolinskyJS. Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory. Clin Genet2014;86:510–520.
LaDucaHStuenkelAJDolinskyJS. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med2014;16:830–837.
MauerCBPirzadeh-MillerSMRobinsonLDEuhusDM. The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience. Genet Med2014;16:407–412.
RainvilleIRRanaHQ. Next-generation sequencing for inherited breast cancer risk: counseling through the complexity. Curr Oncol Rep2014;16:371.
KapoorNSCurcioLDBlakemoreCA. Multigene panel testing detects equal rates of pathogenic BRCA1/2 mutations and has a higher diagnostic yield compared to limited BRCA1/2 analysis alone in patients at risk for hereditary breast cancer. Ann Surg Oncol2015;22:3282–3288.
KurianAWHareEEMillsMA. Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol2014;32:2001–2009.
TungNBattelliCAllenB. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer2015;121:25–33.
YurgelunMBAllenBKaldateRR. Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome. Gastroenterology2015;149:604–613.e620.
RobsonMEBradburyARArunB. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol2015;33:3660–3667.
BoursiBSellaTLibermanE. The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews. Eur J Cancer2013;49:3680–3685.
LiangJLinCHuF. APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis. Am J Epidemiol2013;177:1169–1179.
LockerGYKaulKWeinbergDS. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features. Cancer Genet Cytogenet2006;169:33–38.
PataelYFigerAGershoni-BaruchR. Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi Jews. Eur J Hum Genet1999;7:555–559.
Shtoyerman-ChenRFriedmanEFigerA. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect. Genet Test2001;5:141–146.
LammiLArteSSomerM. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet2004;74:1043–1050.
LejeuneSGuillemotFTribouletJP. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. Hum Mutat2006;27:1064.
MarvinMLMazzoniSMHerronCM. AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome. Am J Med Genet A2011;155A:898–902.
RiveraBPereaJSanchezE. A novel AXIN2 germline variant associated with attenuated FAP without signs of oligondontia or ectodermal dysplasia. Eur J Hum Genet2014;22:423–426.
GronwaldJCybulskiCPiesiakW. Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband. Br J Cancer2009;100:1508–1512.
LiuCWangQSWangYJ. The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis. Asian Pac J Cancer Prev2012;13:2051–2055.
JaegerELeedhamSLewisA. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet2012;44:699–703.
LiebermanSWalshTSchechterM. Features of patients with hereditary mixed polyposis syndrome caused by duplication of GREM1 and implications for screening and surveillance. Gastroenterology2017;152:1876–1880.e1.
IkedaMOrimoHMoriyamaH. Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability. Cancer Res1998;58:594–598.
AdamRSpierIZhaoB. Exome sequencing identifies biallelic MSH3 germline mutations as a recessive subtype of colorectal adenomatous polyposis. Am J Hum Genet2016;99:337–351.
TheodoratouECampbellHTenesaA. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer2010;103:1875–1884.
WinAKClearySPDowtyJG. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer2011;129:2256–2262.
WinAKHopperJLJenkinsMA. Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis. Fam Cancer2011;10:1–9.
WinAKDowtyJGClearySP. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology2014;146:1208–1211.e1–5.
RosnerGBercovichDDanielYE. Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews. Fam Cancer2015;14:427–436.
WerenRDLigtenbergMJKetsCM. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet2015;47:668–671.
BellidoFPinedaMAizaG. POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Genet Med2016;18:325–332.
PallesCCazierJBHowarthKM. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet2013;45:136–144.
ValleLHernandez-IllanEBellidoF. New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. Hum Mol Genet2014;23:3506–3512.
ElsayedFAKetsCMRuanoD. Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer. Eur J Hum Genet2015;23:1080–1084.
SpierIHolzapfelSAltmullerJ. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Int J Cancer2015;137:320–331.
Esteban-JuradoCGimenez-ZaragozaDMunozJ. POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer. Oncotarget2017;8:26732–26743.